Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir-Reference-Cited by-同舟云学术

Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir

Published:2018-12-01 Issue:4 Volume:79 Page:519-526
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

George Elizabeth C.,Bucciardini Raffaella,Richert Laura,Dedes Nikos,Fragola Vincenzo,Nieuwkerk Pythia,Spire Bruno,Volny-Anne Alain,West Brian,Molina Jean-Michel,Horban Andrzej,Fox Julie,Pozniak Anton,Vella Stefano,Termote Monique,Raffi François,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference22 articles.

1. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata;Palella;Ann Intern Med.,2003

2. Initiation of antiretroviral therapy in early asymptomatic HIV infection;Group;N Engl J Med.,2015

3. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research;Marcellin;HIV Clin Trials.,2007

4. Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients;Campo;Int J STD AIDS.,2010

5. Choice of therapeutic strategies in the context of HIV infection: key role of patient-reported outcomes;Marcellin;Expert Rev Anti Infect Ther.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in health and sleep quality after anti-retroviral treatment modification in Japanese people living with HIV;Journal of Infection and Chemotherapy;2023-10

2. Patient-reported outcomes for HIV: the future of long-acting injectables and antiretroviral therapy evaluations;Future Virology;2021-08

3. Grado de satisfacción y conocimiento de pacientes positivos para HIV ante el cambio de tenofovir a tenofovir-alafenamida en tratamientos con emtricitabina y rilpivirina;Biomédica;2020-05-01

4. Five-year follow-up of patients enrolled in the NEAT 001/ANRS 143 randomized clinical trial: NEAT 001/ANRS 143 LONG TERM study;Journal of Antimicrobial Chemotherapy;2020-03-25

5. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study;Clinical Infectious Diseases;2019-12-27